These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

986 related items for PubMed ID: 26942448

  • 21. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
    Wei Y, Gu X, Cheng L, Meng F, Storm G, Zhong Z.
    Acta Biomater; 2019 Jul 01; 92():196-204. PubMed ID: 31102765
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN, Xu QX, Davoodi P, Wang DP, Wang CH.
    Acta Pharmacol Sin; 2017 Jun 01; 38(6):943-953. PubMed ID: 28552909
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
    Hong G, Yuan R, Liang B, Shen J, Yang X, Shuai X.
    Biomed Microdevices; 2008 Oct 01; 10(5):693-700. PubMed ID: 18350380
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X, Ding L, Xu Y, Wang Y, Ping Q.
    Int J Pharm; 2009 May 21; 373(1-2):116-23. PubMed ID: 19429296
    [Abstract] [Full Text] [Related]

  • 29. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y, Che S, Hui B, Yang Y, Wang X, Zhang X, Qiang Y, Ma H.
    Biomed Pharmacother; 2019 Apr 21; 112():108614. PubMed ID: 30798129
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D, Kong YY, Sun JH, Huo SJ, Zhou M, Gui YL, Mu X, Chen H, Yu SQ, Xu Q.
    Int J Nanomedicine; 2017 Apr 21; 12():2081-2108. PubMed ID: 28356731
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J, Li L, Wu L, Sun B, Du Y, Sun J, Wang Y, Fu Q, Zhang P, He Z.
    Eur J Pharm Sci; 2017 Mar 01; 99():185-192. PubMed ID: 27989702
    [Abstract] [Full Text] [Related]

  • 34. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W, Xi M, Duan X, Wang Y, Kong F.
    Int J Nanomedicine; 2015 Mar 01; 10():3737-50. PubMed ID: 26045664
    [Abstract] [Full Text] [Related]

  • 35. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
    Chai F, Sun L, He X, Li J, Liu Y, Xiong F, Ge L, Webster TJ, Zheng C.
    Int J Nanomedicine; 2017 Mar 01; 12():1791-1802. PubMed ID: 28424550
    [Abstract] [Full Text] [Related]

  • 36. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
    Yoo HS, Park TG.
    J Control Release; 2004 Apr 28; 96(2):273-83. PubMed ID: 15081218
    [Abstract] [Full Text] [Related]

  • 37. Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.
    Zhong C, Qiu S, Li J, Shen J, Zu Y, Shi J, Sui G.
    Phytomedicine; 2019 Jun 28; 59():152921. PubMed ID: 31055231
    [Abstract] [Full Text] [Related]

  • 38. Multifunctional SPIO/DOX-loaded A54 Homing Peptide Functionalized Dextran-g-PLGA Micelles for Tumor Therapy and MR Imaging.
    Situ JQ, Wang XJ, Zhu XL, Xu XL, Kang XQ, Hu JB, Lu CY, Ying XY, Yu RS, You J, Du YZ.
    Sci Rep; 2016 Oct 24; 6():35910. PubMed ID: 27775017
    [Abstract] [Full Text] [Related]

  • 39. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
    Guan X, Gao M, Xu H, Zhang C, Liu H, Lv L, Deng S, Gao D, Tian Y.
    Drug Deliv; 2016 Nov 24; 23(9):3307-3318. PubMed ID: 27067032
    [Abstract] [Full Text] [Related]

  • 40. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X, Wang Q, Qin L, Fu H, Fang Y, Han B, Duan Y.
    Drug Deliv; 2016 Oct 24; 23(8):2936-2945. PubMed ID: 26739487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.